Combination of ACEI and ARB therapy increases renal risks in elderly - ModernMedicine Print
ModernMedicine
Combining angiotensin-converting-enzyme (ACE) inhibitors with angiotensin-receptor blockers (ARBs) is associated with increased risk of adverse renal outcomes, according to a recent study published in the Canadian Medical Association Journal.

...